tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

LEGN Stock Latest News

Positive Developments in Carvykti Therapy Propel Legend Biotech to ‘Buy’ Rating
RatingsPositive Developments in Carvykti Therapy Propel Legend Biotech to ‘Buy’ Rating
3d ago
LEGN
Legend Biotech price target lowered to $84.28 from $92.97 at Goldman Sachs
PremiumThe Fly
Legend Biotech price target lowered to $84.28 from $92.97 at Goldman Sachs
30d ago
LEGN
Legend Biotech Reports Q4 CARVYKTI® Sales
PremiumCompany Announcements
Legend Biotech Reports Q4 CARVYKTI® Sales
30d ago
6K
LEGN
Legend Biotech Showcases CAR-T Therapy Success at J.P. Morgan Healthcare Conference
PremiumCompany Announcements
Legend Biotech Showcases CAR-T Therapy Success at J.P. Morgan Healthcare Conference
1M ago
6K
LEGN
Legend Biotech rumor highlighted in Betaville alert
PremiumThe Fly
Legend Biotech rumor highlighted in Betaville alert
1M ago
LEGN
Legend Biotech price target lowered to $84 from $86 at RBC Capital
PremiumThe FlyLegend Biotech price target lowered to $84 from $86 at RBC Capital
1M ago
LEGN
Piper lowers sales estimates for Legend Biotech’s Carvykti
Premium
The Fly
Piper lowers sales estimates for Legend Biotech’s Carvykti
2M ago
JNJ
LEGN
Legend Biotech Announces Employee Transition Agreement
Premium
Company Announcements
Legend Biotech Announces Employee Transition Agreement
2M ago
6K
LEGN
Legend Biotech management to meet with Piper Sandler
PremiumThe Fly
Legend Biotech management to meet with Piper Sandler
2M ago
LEGN
Arcellx price target raised to $114 from $106 at UBS
PremiumThe Fly
Arcellx price target raised to $114 from $106 at UBS
2M ago
ACLX
LEGN
Legend Biotech’s CARVYKTI® Boosts Myeloma Treatment Success
PremiumCompany Announcements
Legend Biotech’s CARVYKTI® Boosts Myeloma Treatment Success
2M ago
6K
LEGN
Legend Biotech’s Phase 3 study of CARVYKTI shows ‘improved disease negativity’
PremiumThe Fly
Legend Biotech’s Phase 3 study of CARVYKTI shows ‘improved disease negativity’
2M ago
LEGN
Gilead price target raised to $115 from $105 at Oppenheimer
PremiumThe FlyGilead price target raised to $115 from $105 at Oppenheimer
2M ago
JNJ
ACLX
3 Best Stocks to Buy Now, 11/13/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 11/13/2024, According to Top Analysts 
3M ago
PGY
RNA
Legend Biotech’s Q3 2024 Sees Strong Sales Growth
Premium
Company Announcements
Legend Biotech’s Q3 2024 Sees Strong Sales Growth
3M ago
LEGN
Legend Biotech Reports Strong Sales Growth in Q3 2024
PremiumCompany Announcements
Legend Biotech Reports Strong Sales Growth in Q3 2024
3M ago
6K
LEGN
Legend Biotech reports Q3 EPS (34c), consensus (42c)
PremiumThe Fly
Legend Biotech reports Q3 EPS (34c), consensus (42c)
3M ago
LEGN
Is LEGN a Buy, Before Earnings?
PremiumPre-Earnings
Is LEGN a Buy, Before Earnings?
3M ago
LEGN
Legend Biotech’s CARVYKTI Shows Promising Myeloma Results
PremiumCompany Announcements
Legend Biotech’s CARVYKTI Shows Promising Myeloma Results
4M ago
6K
LEGN
Legend Biotech appoints Alan Bash as president of Carvykti
PremiumThe FlyLegend Biotech appoints Alan Bash as president of Carvykti
4M ago
LEGN
Legend Biotech participates in a conference call with JPMorgan
Premium
The Fly
Legend Biotech participates in a conference call with JPMorgan
4M ago
LEGN
Legend Biotech Faces Financial Restructuring Amid Voting Changes
Premium
Company Announcements
Legend Biotech Faces Financial Restructuring Amid Voting Changes
4M ago
6K
LEGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >